The all-scrip deal, valued at $91.8 million, came after the retirement village operator's balance date, and lifted Metlifecare's total assets to some $1.9 billion. It increased the number of units to 3,902 from 2,460 and added a further $128.9 million of bank debt to the company's books.
Metlifecare reporting annual operating cash flow of $31 million, beating guidance of $26.5 million, and up from $23 million a year earlier.
Trading and relicensing performance earnings rose to $46 million from $43.3 million.
Metlifecare reported 36 new sales of unit rights for gross settlements of $20.4 million, up from 29 new sales attracting $15.7 million in 2011. Unit rights resales increased to 294 attracting $93.5 million from 267 sales raising $98 million a year earlier.
The board didn't declare a dividend.
The shares rose 2 per cent to $2.60, and are up 12 per cent this year. The stock is rated a 'buy' according to the one analyst recommendation compiled by Reuters, with a target price of $2.725.